|
|
|
Insider
Information: |
Deshpande Milind |
Relationship: |
|
City: |
New Haven |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
53,954 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$99,270 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
53,954 |
|
|
Total
Value |
$99,270 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Achillion Pharmaceuticals Inc |
ACHN |
Chief Executive Office... |
2016-12-02 |
2,500 |
|
0 |
Premium* |
|
Spero Therapeutics Inc |
SPRO |
|
2023-10-05 |
51,454 |
2022-09-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SPRO |
Spero Therapeutics Inc |
|
|
2023-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
51,454 |
0 |
- |
|
SPRO |
Spero Therapeutics Inc |
Director |
|
2022-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
31,454 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Chief Executive Officer |
|
2016-12-02 |
4 |
B |
$4.06 |
$10,150 |
D/D |
2,500 |
2,500 |
2.81 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
President and CEO |
|
2015-01-21 |
4 |
S |
$15.00 |
$1,500,000 |
D/D |
(100,000) |
0 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
President and CEO |
|
2015-01-21 |
4 |
OE |
$3.02 |
$302,000 |
D/D |
100,000 |
100,000 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
President and CEO |
|
2014-08-18 |
4 |
S |
$10.00 |
$2,166,240 |
D/D |
(216,624) |
0 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
President and CEO |
|
2014-08-18 |
4 |
OE |
$1.05 |
$664,262 |
D/D |
216,624 |
124,424 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
President and CSO |
|
2012-03-15 |
4 |
S |
$10.70 |
$56,838 |
D/D |
(5,312) |
0 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
President and CSO |
|
2012-03-15 |
4 |
OE |
$1.05 |
$5,578 |
D/D |
5,312 |
5,312 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
President and CSO |
|
2012-01-09 |
4 |
S |
$9.34 |
$99,238 |
D/D |
(10,625) |
0 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
President and CSO |
|
2012-01-09 |
4 |
OE |
$1.05 |
$11,156 |
D/D |
10,625 |
10,625 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
President and CSO |
|
2011-06-28 |
4 |
S |
$8.05 |
$402,539 |
D/D |
(49,688) |
0 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
President and CSO |
|
2011-06-28 |
4 |
OE |
$1.05 |
$76,579 |
D/D |
49,688 |
49,688 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
President and CSO |
|
2011-06-23 |
4 |
S |
$7.50 |
$36,204 |
D/D |
(4,825) |
0 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
President and CSO |
|
2011-06-22 |
4 |
S |
$7.51 |
$81,068 |
D/D |
(10,800) |
4,825 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Pres R&D and CSO |
|
2011-05-27 |
4 |
S |
$7.01 |
$335,269 |
D/D |
(47,800) |
15,625 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Pres R&D and CSO |
|
2011-05-27 |
4 |
OE |
$1.05 |
$50,190 |
D/D |
47,800 |
63,425 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
SVP and Chief Scientific Ofc.O |
|
2006-10-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,625 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|